From: Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment
Groups | Blood glucose level (mM) | ||
---|---|---|---|
Day 0 | Day 6 | Changes (%) | |
Normal control | 5.8 ± 1.5 | 5.9 ± 1.7 | +1.7 |
Diabetic control | 27.0 ± 1.2 a | 25.4 ± 7.8 | -5.9 |
Diabetic + AL-1 (20 mg/kg) | 24.9 ± 3.1a | 16.8 ± 2.4 b | -32.5 |
Diabetic +AL-1 (40 mg/kg) | 25.0 ± 2.7 a | 13.9 ± 3.4 c | -44.4 |
Diabetic + AL-1 (80 mg/kg) | 24.6 ± 3.2 a | 8.6 ± 3.1 c, d | -65.0 |
Diabetic + Andro (50 mg/kg) | 24.8 ± 3.0 a | 16.8 ± 2.1 b | -32.3 |
Diabetic + Gli (1.2 mg/kg) | 24.7 ± 5.1 a | 10.1 ± 3.0 c, d | -59.1 |